» Articles » PMID: 1656368

Murine Flt3, a Gene Encoding a Novel Tyrosine Kinase Receptor of the PDGFR/CSF1R Family

Overview
Journal Oncogene
Date 1991 Sep 1
PMID 1656368
Citations 54
Authors
Affiliations
Soon will be listed here.
Abstract

Receptor-type tyrosine kinases presenting an extracellular region with five immunoglobulin-like domains, and strongly related by sequence similarities in the intracellular region, constitute a family of receptors involved in development and function of various cell lineages. We have isolated and characterized the mouse Flt3 gene, encoding the sixth member of this family. The Flt3 gene possesses an open reading frame of 3000 nucleotides, and therefore appears to code for a protein of 1000 amino acids. The deduced structure of the FLT3 protein presents all the characteristics of a receptor-type kinase of this family. The gene is expressed in placenta, in various adult tissues including gonads and brain, and in hematopoietic cells. The Flt3 transcript is 3.7 kb long, except in the testis, where two shorter post-meiotic transcripts are detected. These results suggest a role for this novel receptor and its yet unidentified ligand in placenta, gonads and hematopoietic and nervous systems.

Citing Articles

Oncogenic FLT3 internal tandem duplications (ITD) and CD45/PTPRC control osteoclast functions and bone microarchitecture.

Lossius-Cott C, Annoh A, Bens M, Nietzsche S, Hoffmann B, Figge M JBMR Plus. 2025; 9(3):ziae173.

PMID: 39906260 PMC: 11788565. DOI: 10.1093/jbmrpl/ziae173.


Clinical profile of -ITD mutation in West Algerian population with acute myeloid leukemia.

Moghtit F, Boughrara W, Dorgham S, Koriche I, Ouahba I, Ammour A Mol Biol Res Commun. 2024; 13(3):175-182.

PMID: 38915455 PMC: 11194026. DOI: 10.22099/mbrc.2024.49437.1955.


FLT3L governs the development of partially overlapping hematopoietic lineages in humans and mice.

Momenilandi M, Levy R, Sobrino S, Li J, Lagresle-Peyrou C, Esmaeilzadeh H Cell. 2024; 187(11):2817-2837.e31.

PMID: 38701783 PMC: 11149630. DOI: 10.1016/j.cell.2024.04.009.


FLT3 inhibitors for acute myeloid leukemia: successes, defeats, and emerging paradigms.

Acharya B, Saha D, Armstrong D, Lakkaniga N, Frett B RSC Med Chem. 2022; 13(7):798-816.

PMID: 35923716 PMC: 9298189. DOI: 10.1039/d2md00067a.


Sex disparity in acute myeloid leukaemia with FLT3 internal tandem duplication mutations: implications for prognosis.

Hellesoy M, Engen C, Grob T, Lowenberg B, Valk P, Gjertsen B Mol Oncol. 2021; 15(9):2285-2299.

PMID: 34101344 PMC: 8410575. DOI: 10.1002/1878-0261.13035.